SAMUEL MBURU: Open Payments
NPI 1497438378 · GRAFTON, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 35 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $440 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $190 |
| Novo Nordisk Inc | 13 | $147 |
| Phathom Pharmaceuticals, Inc. | 5 | $64 |
| Boston Scientific Corporation | 1 | $26 |
| ABBVIE INC. | 1 | $23 |
| Viatris Specialty LLC | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| Electromed, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: OTEZLA, Ozempic, EVENITY, VOQUEZNA, Wegovy, Intracept, LILETTA, YUPELRI.
Industry payments across ND — which companies pay providers there.
